These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 16716349)

  • 1. Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC.
    Chen X; Zankl A; Niroomand F; Liu Z; Katus HA; Jahn L; Tiefenbacher C
    J Mol Cell Cardiol; 2006 Jul; 41(1):26-33. PubMed ID: 16716349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP).
    Fiori JL; Billings PC; de la Peña LS; Kaplan FS; Shore EM
    J Bone Miner Res; 2006 Jun; 21(6):902-9. PubMed ID: 16753021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
    Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
    Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of bone morphogenetic protein 2 on Id expression and neuroblastoma cell differentiation.
    Du Y; Yip H
    Differentiation; 2010 Feb; 79(2):84-92. PubMed ID: 19889495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of bone morphogenetic protein binding sites and Smad1/5 activation in human vascular cells.
    Upton PD; Long L; Trembath RC; Morrell NW
    Mol Pharmacol; 2008 Feb; 73(2):539-52. PubMed ID: 17989347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal and spatial regulation of bone morphogenetic protein signaling in late lung development.
    Alejandre-Alcázar MA; Shalamanov PD; Amarie OV; Sevilla-Pérez J; Seeger W; Eickelberg O; Morty RE
    Dev Dyn; 2007 Oct; 236(10):2825-35. PubMed ID: 17823941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells.
    Mern DS; Hoppe-Seyler K; Hoppe-Seyler F; Hasskarl J; Burwinkel B
    Breast Cancer Res Treat; 2010 Dec; 124(3):623-33. PubMed ID: 20191379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
    Kuo PL; Hsu YL; Chang CH; Chang JK
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects and target genes of bone morphogenetic protein 6 in Jurkat TAg cells.
    Sivertsen EA; Huse K; Hystad ME; Kersten C; Smeland EB; Myklebust JH
    Eur J Immunol; 2007 Oct; 37(10):2937-48. PubMed ID: 17899540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo.
    Yang J; Li X; Al-Lamki RS; Southwood M; Zhao J; Lever AM; Grimminger F; Schermuly RT; Morrell NW
    Circ Res; 2010 Jul; 107(2):252-62. PubMed ID: 20522807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of bone morphogenetic protein 2 (BMP2) stimulated inhibitor of DNA binding 3 (Id3) transcription.
    Ho CC; Zhou X; Mishina Y; Bernard DJ
    Mol Cell Endocrinol; 2011 Jan; 332(1-2):242-52. PubMed ID: 21056086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-9 induces osteoblast differentiation through the CD44/Smad signaling pathway.
    Tanikawa R; Tanikawa T; Hirashima M; Yamauchi A; Tanaka Y
    Biochem Biophys Res Commun; 2010 Apr; 394(2):317-22. PubMed ID: 20206131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K; Hashimoto T; Kitamura N; Tanaka T
    Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ionizing radiation shifts the PAI-1/ID-1 balance and activates notch signaling in endothelial cells.
    Scharpfenecker M; Kruse JJ; Sprong D; Russell NS; Ten Dijke P; Stewart FA
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):506-13. PubMed ID: 19147015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
    Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
    Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas.
    Nickl-Jockschat T; Arslan F; Doerfelt A; Bogdahn U; Bosserhoff A; Hau P
    Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription regulation of the vegf gene by the BMP/Smad pathway in the angioblast of zebrafish embryos.
    He C; Chen X
    Biochem Biophys Res Commun; 2005 Apr; 329(1):324-30. PubMed ID: 15721310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function.
    Abdelmagid SM; Barbe MF; Arango-Hisijara I; Owen TA; Popoff SN; Safadi FF
    J Cell Physiol; 2007 Jan; 210(1):26-37. PubMed ID: 17034042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endofin acts as a Smad anchor for receptor activation in BMP signaling.
    Shi W; Chang C; Nie S; Xie S; Wan M; Cao X
    J Cell Sci; 2007 Apr; 120(Pt 7):1216-24. PubMed ID: 17356069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.